Ipsen header image

Ipsen

IPN

Equity

ISIN FR0010259150 / Valor 2348805

Euronext - Euronext Paris (2026-11-06)
EUR 158.70-0.44%

Ipsen
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Ipsen is a France-based, research-driven biopharmaceutical company that develops, manufactures and commercializes specialty-care medicines with a focus on oncology, rare diseases and neuroscience. Its marketed portfolio includes treatments such as Somatuline (lanreotide) for neuroendocrine tumors and acromegaly, Decapeptyl (triptorelin) in endocrine and oncology indications, and Dysport (abobotulinumtoxinA) for certain neurological and aesthetic uses; the group builds its business through internal R&D, acquisitions and licensing partnerships to advance a pipeline of targeted and rare-disease therapies and to support global commercial operations across Europe, North America and Asia.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

28.9%1Y
43.1%3Y
84.7%5Y

Performance

29.8%1Y
26.2%3Y
28.1%5Y

Volatility

Market cap

14631 M

Market cap (USD)

Daily traded volume (Shares)

143,497

Daily traded volume (Shares)

1 day high/low

110.8 / 109.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Jubilant Pharmova Limited
Jubilant Pharmova Limited Jubilant Pharmova Limited Valor: 2477953
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%INR 938.60
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 101.00
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.70%EUR 85.26
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.57%USD 62.14
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%EUR 11.34
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.97%USD 69.74
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.62%USD 271.83
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.82%USD 23.40
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%EUR 6.32
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-13.06%EUR 0.55